Crossmark

Targeting Nanomedicines to Prostate Cancer: Evaluation of Specificity of Ligands to Two Different Receptors In Vivo

Published Online: 2016-05-25

Published Print: 2016-10

Authors

Pearce, Amanda K.

Fuchs, Adrian V.

Fletcher, Nicholas L.

Thurecht, Kristofer J.
Funding

Funding for this research was provided by:

Australian Research Council (FT110100284, DP140100951)

National Health and Medical Research Council (APP1099321)
License Information

Text and Data Mining valid from 2016-05-25

Version of Record valid from 2016-05-25
More Information

Article History

Received: 5 April 2016

Accepted: 11 May 2016

First Online: 25 May 2016

Document is current